In today’s recent session, 1.99 million shares of the Rocket Pharmaceuticals Inc (NASDAQ:RCKT) have been traded, and its beta is 0.99. Most recently the company’s share price was $14.64, and it changed around $1.13 or 8.40% from the last close, which brings the market valuation of the company to $1.33B. RCKT at last check was trading at a discount to its 52-week high of $32.53, offering almost -122.2% off that amount. The share price’s 52-week low was $12.62, which indicates that the recent value has risen by an impressive 13.8% since then. We note from Rocket Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 0.75 million shares, with the 3-month average coming to 935.33K.

Rocket Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.13. If we narrow it down even further, the data shows that 0 out of 16 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 1 recommended RCKT as a Hold, whereas 11 deemed it a Buy, and 0 rated it as Underweight.

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) trade information

Instantly RCKT has been showing a green trend so far today with a performance of 8.40% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 14.47 on recent trading daydecreased the stock’s daily price by -1.17%. The company’s shares are currently down -51.14% year-to-date, but still up 7.84% over the last five days. On the other hand, Rocket Pharmaceuticals Inc (NASDAQ:RCKT) is -13.14% down in the 30-day period. We can see from the shorts that 10.39 million shares have been sold at a short interest cover period of 10.98 day(s).

The consensus price target as assigned by Wall Street analysts is $42, which translates to bulls needing to increase their stock price by 65.14% from its current value. Analyst projections state that RCKT is forecast to be at a low of $39 and a high of $45.

Rocket Pharmaceuticals Inc (RCKT) estimates and forecasts

Rocket Pharmaceuticals Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -35.57 percent over the past six months and at a 2.40% annual growth rate that is well below the industry average of 17.20%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -9.09%. Rocket Pharmaceuticals Inc earnings are expected to increase by 2.49% in 2024, but the outlook is positive 41.70% per year for the next five years.

RCKT Dividends

Rocket Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in January.

Rocket Pharmaceuticals Inc (NASDAQ:RCKT)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 3.38% of Rocket Pharmaceuticals Inc shares, and 107.14% of them are in the hands of institutional investors. The stock currently has a share float of 110.89%. Rocket Pharmaceuticals Inc stock is held by 289.0 institutions, with RTW INVESTMENTS, LP being the largest institutional investor. By 2024-06-30, it held 18.8677% of the shares, which is about 17.69 million shares worth $380.82 million.

WELLINGTON MANAGEMENT GROUP LLP, with 9.7665% or 9.16 million shares worth $197.12 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Jul 31, 2024. The former held 6.49 shares worth $94.01 million, making up 7.12% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 2.21 shares worth around $32.08 million, which represents about 2.43% of the total shares outstanding.